TICKERNERD
Menu
RVPRVPHealthcare · Medical Instruments & Supplies

RVP Stock Forecast: Retractable Technologies, Inc. Price Predictions for 2026-2027

Last close, 24 Aug 2026
$0.73
0.00% on the day

Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 62 of 100 as at 22 Aug 2026 — in the upper half.

Market cap
$21.9M
Ticker Nerd rank
62 / 100
Median analyst target
—
Analysts covering
0
Revenue$7.2M
Operating income−$4.7M
Net income−$4.2M
Free cash flow−$1.4M
Quarterly, 8 quarters to 31 Mar 2026 · latest quarter's figure shown
Total return, dividends reinvested
1W
+4.3%
1M
+7.4%
YTD
−5.2%
1Y
−12.0%
From 52W high
−31.1%
From 52W low
+17.7%
$0.62
$1.06
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

RVP stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores Retractable Technologies, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 22 Aug 2026
62 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Volatility
96
Size
88
Growth
85
Issuance
78
Accruals
61
Momentum
54
Quality
45
Revisions
25
Value
10

Volatility (96): The share price has been relatively steady.

Value (10): The shares cost a lot relative to the profits and assets behind them.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

RVP stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on RVP, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$0.60$0.70$0.80$0.90$1.00$1.10Oct 25Jan 26Apr 26Jul 26RVP

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. RVP appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

Performance

RVP vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 24 Aug 2026, Retractable Technologies, Inc. returned −12.0% against +19.6% for the S&P 500, dividends included.

RVP vs S&P 500, last 12 monthsTotal return, rebased to 100
708090100110120130Oct 25Jan 26Apr 26Jul 26RVPS&P 500

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

RVP analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Fundamentals

Retractable Technologies, Inc. (RVP) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
8.1×

Cheaper than 62% of US stocks

Price / sales
0.6×

Cheaper than 79% of US stocks

Price / book
0.3×

Cheaper than 88% of US stocks

EV / EBITDA
1.2×

Cheaper than 57% of US stocks

Growth & margins
Revenue growth (YoY)
−31.1%

Higher than 8% of US stocks

Earnings growth (YoY)
—
Gross margin
−11.7%

Higher than 4% of US stocks

Operating margin
−71.5%

Higher than 15% of US stocks

Net margin
−9.9%

Higher than 20% of US stocks

Returns & dividend
Return on equity
−4.5%

Higher than 40% of US stocks

Return on assets
−9.4%

Higher than 27% of US stocks

Dividend yield
—

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

Retractable Technologies, Inc. (RVP) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • Retractable Technologies, Inc. has a market value of $21.9M and an enterprise value of −$16.8M.

  • Revenue in the twelve months to 31 Mar 2026: $37.1M. The latest quarter shrank 31.1% year on year.

  • Net income over the same four quarters: −$6.3M, a −16.9% net margin.

  • Free cash flow in the twelve months to 31 Mar 2026: −$7.4M, after $455K of capital spending.

  • Retractable Technologies, Inc. spent $230K on dividends in the twelve months to 31 Mar 2026.

  • Shares outstanding: 29.9M.

  • Trailing P/E: 8.1×.

  • Retractable Technologies, Inc. employs 195 people — $191K of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 31 Mar 2026 · market figures as at 25 Aug 2026

Data provided by Twelve Data

Peers

RVP vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelMedical Instruments & Supplies
CompanyMarket capTKN rank
RVPRetractable Technologies, Inc.$21.9M
62
ZJYLJin Medical International Ltd.$23.8M
22
FEMYFemasys, Inc.$24.8M
50
RGNTRegentis Biomaterials Ltd.$14.8M
14
HBIOHarvard Bioscience, Inc.$33.5M
98
BNGOBionano Genomics, Inc.$14.1M
72
MLSSMilestone Scientific, Inc.$42.3M
85

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own Retractable Technologies, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest RVP news & analysis

RVP Stock Gains Post Q2 Earnings Despite Fall in Sales & Unit Volumes

Zacks Investment Research · 20 Aug 2026negative

Retractable Technologies reported second-quarter 2026 results in which sales weakened due to EasyPoint order timing, while investment gains drove earnings. Tariffs remain a key sourcing challenge for the company.

Why it matters — RVP watchers would care because the quarter reflects softer sales and unit volumes offset by investment gains, with tariffs posing an ongoing sourcing challenge.

Retractable Technologies, Inc. Results for the Periods Ended June 30, 2026

Business Wire · 14 Aug 2026negative

Retractable Technologies reported total net sales of $7.2 million for Q2 2026 and an operating loss of $5.1 million, compared to net sales of $10.4 million and the same operating loss of $5.1 million in Q2 2025. For the first half of 2026, net sales were $14.4 million with operating losses of $11.3 million versus net revenues of $18.7 million and an operating loss in the prior-year period.

Why it matters — The results show a significant decline in sales for both the quarter and first half of 2026 compared to the same periods in 2025, while operating losses persisted.

FAQ

Frequently asked questions about RVP stock

How does Ticker Nerd's model rank RVP?

As at 22 Aug 2026, Retractable Technologies, Inc. ranks 62 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Volatility (96 of 100).

What is the RVP stock forecast for 2030?

No analyst covering Retractable Technologies, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for RVP are extrapolating price history, which says nothing about the business.

How has RVP stock performed over the past year?

Retractable Technologies, Inc. returned -12.0% over the 12 months to 24 Aug 2026, with dividends reinvested. Past performance does not indicate future returns.

What does Retractable Technologies, Inc. do?

Retractable Technologies Inc. is a prominent player in the medical device industry, known for its commitment to improve safety in medical environments.

What is the latest news on RVP?

The most recent item we track (Zacks Investment Research, 20 Aug 2026): "RVP Stock Gains Post Q2 Earnings Despite Fall in Sales & Unit Volumes". Retractable Technologies reported second-quarter 2026 results in which sales weakened due to EasyPoint order timing, while investment gains drove earnings. Tariffs remain a key sourcing challenge for the company.

Company

About Retractable Technologies, Inc.

Retractable Technologies Inc. is a prominent player in the medical device industry, known for its commitment to improve safety in medical environments. The company specializes in the design, manufacturing, and marketing of safety medical devices, with its primary products being retractable and injection needle systems. These innovative devices are crafted to minimize risks of accidental needle-stick injuries and reduce opportunities for cross-contamination, thereby enhancing safety for healthcare professionals and patients alike. Retractable Technologies Inc.'s products cater to hospitals, clinics, medical facilities, and other healthcare providers across the globe. By providing solutions that address critical safety issues in healthcare settings, the company plays a vital role in public health and safety. With a focus on technological innovation and quality, Retractable Technologies Inc. continues to influence best practices in medical device safety, contributing to safer clinical outcomes and nurturing trust within the healthcare industry.

CEO Mr. Thomas J. Shaw · 195 employees · United States · https://www.retractable.com